Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125179052 | 12517905 | 2 | F | 20160707 | 20160630 | 20160721 | EXP | US-PFIZER INC-2016309505 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20160721 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125179052 | 12517905 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | 190 MG, 1X/DAY (Q24 X7) | U | 72168 | 190 | MG | SOLUTION FOR INJECTION | QD | ||||||
| 125179052 | 12517905 | 2 | SS | DAUNORUBICIN HCL | DAUNORUBICIN HYDROCHLORIDE | 1 | 116 MG, (Q24 DAYS 1-3) | U | 0 | 116 | MG | ||||||||
| 125179052 | 12517905 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 125179052 | 12517905 | 4 | C | ASA | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 125179052 | 12517905 | 5 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 125179052 | 12517905 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 2.5 MG, UNK | 0 | 2.5 | MG | |||||||||
| 125179052 | 12517905 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125179052 | 12517905 | 1 | Acute myeloid leukaemia |
| 125179052 | 12517905 | 2 | Acute myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125179052 | 12517905 | OT |
| 125179052 | 12517905 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125179052 | 12517905 | Abdominal pain | |
| 125179052 | 12517905 | Acute myeloid leukaemia | |
| 125179052 | 12517905 | Asthenia | |
| 125179052 | 12517905 | Atrial fibrillation | |
| 125179052 | 12517905 | Cardiac failure congestive | |
| 125179052 | 12517905 | Cough | |
| 125179052 | 12517905 | Disease progression | |
| 125179052 | 12517905 | Dizziness | |
| 125179052 | 12517905 | Dyspnoea exertional | |
| 125179052 | 12517905 | Fatigue | |
| 125179052 | 12517905 | Febrile neutropenia | |
| 125179052 | 12517905 | Headache | |
| 125179052 | 12517905 | Hiatus hernia | |
| 125179052 | 12517905 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |